首页> 外文会议>SPIE Conference on Medical imaging >Coronary DSA: Enhancing Coronary Tree Visibility throughDiscriminative Learning and Robust Motion Estimation
【24h】

Coronary DSA: Enhancing Coronary Tree Visibility throughDiscriminative Learning and Robust Motion Estimation

机译:冠状动脉DSA:通过Discriminative学习和强大的运动估计增强冠状动脉树的可视性

获取原文
获取外文期刊封面目录资料

摘要

Digital subtraction angiography (DSA) is a well-known technique for improving the visibility and perceptibility of blood vessels in the human body. Coronary DSA extends conventional DSA to dynamic 2D fluoroscopic sequences of coronary arteries which are subject to respiratory and cardiac motion. Effective motion compensation is the main challenge for coronary DSA. Without a proper treatment, both breathing and heart motion can cause unpleasant artifacts in coronary subtraction images, jeopardizing the clinical value of coronary DSA. In this paper, we present an effective method to separate the dynamic layer of background structures from a fluoroscopic sequence of the heart, leaving a clean layer of moving coronary arteries. Our method combines the techniques of learning-based vessel detection and robust motion estimation to achieve reliable motion compensation for coronary sequences. Encouraging results have been achieved on clinically acquired coronary sequences, where the proposed method considerably improves the visibility and perceptibility of coronary arteries undergoing breathing and cardiac movement. Perceptibility improvement is significant especially for very thin vessels. The potential clinical benefit is expected in the context of obese patients and deep angulation, as well as in the reduction of contrast dose in normal size patients.
机译:数字减法血管造影(DSA)是一种公知的技术,用于改善人体中血管的可见性和可见性。冠状动脉DSA将常规DSA扩展到冠状动脉的动态2D荧光透视序列,其受呼吸和心动运动。有效的运动补偿是冠状动脉DSA的主要挑战。如果没有适当的治疗,既呼吸和心脏运动可以在冠状动脉减法像引起不愉快的文物,危害冠状动脉DSA的临床应用价值。在本文中,我们提出了一种从心脏的荧光透视序列分离背景结构的动态层,留下了一种流动的冠状动脉。我们的方法结合了基于学习的血管检测和鲁棒运动估计的技术,以实现冠状动脉序列的可靠运动补偿。在临床上获得的冠状动脉序列中取得了令人鼓舞的结果,其中提出的方法大大提高了呼吸和心脏运动的冠状动脉的可见性和可见性。可感知性改善特别适用于非常薄的血管。预计在肥胖患者和深度角度的背景下,预计潜在的临床益处,以及在正常大小患者中的对比剂量减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号